Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arch Therapeutics Inc (OTCQB:ARTH)

0.605
Delayed Data
As of Dec 02
 +0.0222 / +3.81%
Today’s Change
0.16
Today|||52-Week Range
0.95
+199.50%
Year-to-Date
No recent news for Arch Therapeutics Inc.

Today’s Trading

Previous close0.58
Today’s open0.59
Day’s range0.59 - 0.62
Volume234,315
Average volume (3 months)471,919
Market cap$83.4M
Dividend yield--
Data as of 3:38pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+66.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book42.25

Competitors

No competitors data available.

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$0.00
Annual profit (last year)-$2.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Terrence W. Norchi
Chief Financial Officer &
Treasurer
Richard E. Davis
Corporate headquarters
Framingham, Massachusetts

Forecasts


Search for Jobs